Advertisement

Epicardial fat thickness is significantly increased and related to LDL cholesterol level in patients with familial hypercholesterolemia

  • Yurdaer DönmezEmail author
  • Atilla Bulut
Original Article
  • 21 Downloads

Abstract

Purpose

Increased epicardial fat thickness (EFT) is accepted as a risk factfcardiovascular diseases in some studies. There are conflicting results about the relation between plasma low-density lipoprotein cholesterol (LDL-C) level and EFT. As well, the relation between EFT and familial hypercholesterolemia is not clearly documented in the literature. Our aim was to investigate EFT in familial hypercholesterolemia patients and to determine which parameters were related to EFT increase.

Methods

A total of 150 subjects enrolled in our study. Subjects were separated into two groups: 75 hypercholesterolemia patients (16 men, mean age 52.8 ± 7.4 years) and 75 familial hypercholesterolemia patients (26 men, mean age 50.7 ± 9.2 years). Medical history assessments and complete physical examinations were done. Routine laboratory tests and echocardiographic measurements were performed.

Results

Coronary artery disease frequency was significantly higher in the familial hypercholesterolemia group (p < 0.001). This group had significantly higher TC and LDL-C levels than the hypercholesterolemia group (p < 0.05 for all). EFT values were higher in the familial hypercholesterolemia group, and were significantly different than in the other group (p < 0.001). LDL-C was found to be independently related to EFT in the linear regression analysis.

Conclusions

Epicardial fat thickness increased in the familial hypercholesterolemia patients. In addition, LDL-C levels were significantly crelated with increased EFT.

Keywords

Epicardial fat thickness Familial hypercholesterolemia 

Notes

Compliance with ethical standards

Conflict of interest

The auths declare that they have no conflict of interest.

Ethical approval

All procedures perfmed in studies involving human participants were in accdance with the ethical standards of the institutional and/national research committee and with the 1964 Helsinki declaration and its later amendmentscomparable ethical standards.

Informed consent

Informed consent was obtained from all individual participants included in the study.

References

  1. 1.
    Bertaso AG, Bertol D, Duncan BB, Foppa M (2013) Epicardial fat: definition, measurements and systematic review of main outcomes. Arq Bras Cardiol 101:18–28.  https://doi.org/10.5935/abc.20130138 Google Scholar
  2. 2.
    Iacobellis G, Willens HJ (2009) Echocardiographic epicardial fat: a review of research and clinical applications. J Am Soc Echocardiogr 22:1311–1319.  https://doi.org/10.1016/j.echo.2009.10.013 CrossRefGoogle Scholar
  3. 3.
    Ding J, Hsu FC, Harris TB, Liu Y, Kritchevsky SB, Szklo M et al (2009) The association of pericardial fat with incident coronary heart disease: the Multi-Ethnic Study of Atherosclerosis (MESA). Am J Clin Nutr 90:499–504.  https://doi.org/10.3945/ajcn.2008.27358 CrossRefGoogle Scholar
  4. 4.
    Schäffler A, Schölmerich J (2010) Innate immunity and adipose tissue biology. Trends Immunol 31:228–235.  https://doi.org/10.1016/j.it.2010.03.001 CrossRefGoogle Scholar
  5. 5.
    Sacks HS, Fain JN, Cheema P, Bahouth SW, Garrett E, Wolf RY et al (2011) Inflammatory genes in epicardial fat contiguous with coronary atherosclerosis in the metabolic syndrome and type 2 diabetes: changes associated with pioglitazone. Diabetes Care 34:730–733.  https://doi.org/10.2337/dc10-2083 CrossRefGoogle Scholar
  6. 6.
    Rosito GA, Massaro JM, Hoffmann U, Ruberg FL, Mahabadi AA, Vasan RS et al (2008) Pericardial fat, visceral abdominal fat, cardiovascular disease risk factors, and vascular calcification in a community-based sample: the framingham heart study. Circulation 117:605–613.  https://doi.org/10.1161/CIRCULATIONAHA.107.743062 CrossRefGoogle Scholar
  7. 7.
    Mahabadi AA, Lehmann N, Kälsch H, Robens T, Bauer M, Dykun I et al (2014) Association of epicardial adipose tissue with progression of coronary artery calcification is more pronounced in the early phase of atherosclerosis: results from the Heinz Nixdorf recall study. JACC Cardiovasc Imaging 7:909–916.  https://doi.org/10.1016/j.jcmg.2014.07.002 CrossRefGoogle Scholar
  8. 8.
    Calabuig Á, Barba J, Guembe MJ, Díez J, Berjón J, Martínez-Vila E et al (2017) Epicardial adipose tissue in the general middle-aged population and its association with metabolic syndrome. Rev Esp Cardiol (Engl Ed) 70:254–260.  https://doi.org/10.1016/j.rec.2016.08.001 CrossRefGoogle Scholar
  9. 9.
    Tanindi A, Erkan AF, Ekici B (2015) Epicardial adipose tissue thickness can be used to predict major adverse cardiac events. Coron Artery Dis 26:686–691.  https://doi.org/10.1097/MCA.0000000000000296 CrossRefGoogle Scholar
  10. 10.
    Nordestgaard BG, Chapman MJ, Humphries SE, Ginsberg HN, Masana L, Descamps OS et al (2013) Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society. Eur Heart J 34:3478–3490.  https://doi.org/10.1093/eurheartj/eht273 CrossRefGoogle Scholar
  11. 11.
    Lear SA, Humphries KH, Kohli S, Frohlich JJ, Birmingham CL, Mancini GB (2007) Visceral adipose tissue, a potential risk factor for carotid atherosclerosis: results of the Multicultural Community Health Assessment Trial (M-CHAT). Stroke 38:2422–2429.  https://doi.org/10.1161/STROKEAHA.107.484113 CrossRefGoogle Scholar
  12. 12.
    Mangili LC, Mangili OC, Bittencourt MS, Miname MH, Harada PH, Lima LM et al (2016) Epicardial fat is associated with severity of subclinical coronary atherosclerosis in familial hypercholesterolemia. Atherosclerosis 254:73–77.  https://doi.org/10.1016/j.atherosclerosis.2016.09.010 CrossRefGoogle Scholar
  13. 13.
    Iwayama T, Nitobe J, Watanabe T, Ishino M, Tamura H, Nishiyama S et al (2014) Role of epicardial adipose tissue in coronary artery disease in non-obese patients. J Cardiol 63:344–349.  https://doi.org/10.1016/j.jjcc.2013.10.002 CrossRefGoogle Scholar
  14. 14.
    Williams RR, Hunt SC, Schumacher MC, Hegele RA, Leppert MF, Ludwig EH et al (1993) Diagnosing heterozygous familial hypercholesterolemia using new practical criteria validated by molecular genetics. Am J Cardiol 72:171–176.  https://doi.org/10.1016/0002-9149(93)90155-6 CrossRefGoogle Scholar
  15. 15.
    Jellinger PS, Handelsman Y, Rosenblit PD, Bloomgarden ZT, Fonseca VA, Garber AJ et al (2017) American Association of Clinical Endocrinologists and American College of Endocrinology Guidelines for Management of dyslipidemia and prevention of cardiovascular disease. Endocr Pract 23:1–87.  https://doi.org/10.4158/EP171764.APPGL CrossRefGoogle Scholar
  16. 16.
    Sahn DJ, DeMaria A, Kisslo J, Weyman A (1978) Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 58:1072–1083.  https://doi.org/10.1161/01.CIR.58.6.1072 CrossRefGoogle Scholar
  17. 17.
    Şeker T, Türkoğlu C, Harbalıoğlu H, Gür M (2018) Epicardial fat thickness is associated with abnormal left ventricle geometry in newly diagnosed hypertension. Acta Cardiol Sin 34:280–287.  https://doi.org/10.6515/ACS.201805_34(3).20171209A Google Scholar
  18. 18.
    Iacobellis G, Ribaudo MC, Zappaterreno A, Iannucci CV, Leonetti F (2004) Relation between epicardial adipose tissue and left ventricular mass. Am J Cardiol 94:1084–1087.  https://doi.org/10.1016/j.amjcard.2004.06.075 CrossRefGoogle Scholar
  19. 19.
    Cheng VY, Dey D, Tamarappoo B, Nakazato R, Gransar H, Miranda-Peats R et al (2010) Pericardial fat burden on ECG-gated noncontrast CT in asymptomatic patients who subsequently experience adverse cardiovascular events. JACC Cardiovasc Imaging 3:352–360.  https://doi.org/10.1016/j.jcmg.2009.12.013 CrossRefGoogle Scholar
  20. 20.
    Ding J, Kritchevsky SB, Hsu FC, Harris TB, Burke GL, Detrano RC et al (2008) Association between non-subcutaneous adiposity and calcified coronary plaque: a sub-study of the Multi-Ethnic Study of Atherosclerosis. Am J Clin Nutr 88:645–650.  https://doi.org/10.1093/ajcn/88.3.645 CrossRefGoogle Scholar
  21. 21.
    Cademartiri F, Di Cesare E, Francone M, Ballerini G, Ligabue G, Maffei E et al (2015) Italian registry of cardiac computed tomography. Radiol Med 120:919–929.  https://doi.org/10.1007/s11547-015-0518-0 CrossRefGoogle Scholar
  22. 22.
    Di Cesare E, Cademartiri F, Carbone I, Carriero A, Centonze M, De Cobelli F et al (2013) Clinical indications for the use of cardiac MRI. By the SIRM study group on cardiac imaging. Radiol Med 118:752–798.  https://doi.org/10.1007/s11547-012-0899-2 CrossRefGoogle Scholar
  23. 23.
    Iacobellis G, Willens HJ, Barbaro G, Sharma AM (2008) Threshold values of high risk echocardiographic epicardial fat thickness. Obesity (Silver Spring) 16:887–892.  https://doi.org/10.1038/oby.2008.6 CrossRefGoogle Scholar
  24. 24.
    Abbara S, Desai JC, Cury RC, Butler J, Nieman K, Reddy V (2006) Mapping epicardial fat with multi-detector computed tomography to facilitate percutaneous transepicardial arrhythmia ablation. Eur J Radiol 57:417–422.  https://doi.org/10.1016/j.ejrad.2005.12.030 CrossRefGoogle Scholar

Copyright information

© Società Italiana di Ultrasonologia in Medicina e Biologia (SIUMB) 2019

Authors and Affiliations

  1. 1.Department of Cardiology, Adana Health Practices and Research CentreUniversity of Health SciencesAdanaTurkey

Personalised recommendations